 |
|
Ebola virus: from wildlife to dogs
April 04, 2005Ebola virus infection in humans provokes a violent haemorrhagic fever. It usually flares up as intense epidemics. These kill 80 % of the people infected. Seven such outbreaks have hit Gabon and the Republic of Congo since 1994, leading to 445 cases resulting in 361 deaths. Ebola virus thus constitutes a grave public health problem in these countries. No medicine or vaccine is currently available, only prevention and rapid control of epidemics by isolation of disease victims can limit its spreading.
Since 2001, IRD research scientists and their partners (1) have been working to unravel the virus's biological cycle, in other words the whole range of ways in which the virus circulates in its natural environment, from its natural host (or reservoir) right up to humans. They showed that strong epidemics of Ebola have decimated populations of large primates over the past several years in the border regions between Gabon and the Republic of Congo. Human infection appears to occur only in a secondary way, through contact with carcasses of dead animals (2). However, the virus's natural cycle is not restricted just to transmission from the reservoir to the non-human primate and then to humans. It is quite possible that several reservoir species co-existent and that many other animal species can become infected, thus contributing to propagation of the virus in nature.
A serological investigation conducted from 1980 to 2000 on 790 nonhuman primates from Cameroon, Gabon and the Republic of Congo, belonging to 20 different species, hence revealed that 12.9 % of wild chimpanzees carry Ebola virus antibodies, several of the positive samples dating from before the first epidemics in these countries. These results therefore indicate that chimpanzees are regularly in contact with the animal virus reservoir and that some of them develop non-fatal infections. The presence of specific antibodies in the animals taken before the epidemics means that the Ebola virus has probably been circulating for a long time in Central African forests. The detection of such antibodies in other primate species (including 5 drills, 1 baboon and 1 mandrill) suggests that circulation of the virus involved many contamination events between distinct animal species. Thus, the multiplicity of infected species, their different susceptibilities to the virus and the great differences in their ways of life, are indicators of the complexity of Ebola virus's circulation in its natural environment. These observations also show that an epidemic or sporadic cases can appear at any moment in the sub-region of Central Africa as a whole.
Moreover, during the latest epidemics in Gabon and the Republic of Congo, there were many cases where dogs had eaten remains of dead animals infected with the virus, nonetheless without showing visible clinical signs. In order to confirm that these dogs had indeed come into contact with the virus, the scientists looked for the presence of specific Ebola virus antibodies in their blood (3). The percentage of dogs carrying such antibodies increases linearly and significantly the closer they are found to foci of the outbreaks. From 9 % in the two large cities of Gabon, antibody prevalence goes up to 25 % in the untouched villages of the epidemic area, reaching 32 % in the villages where human cases have been attributed to an infected-animal source. These domestic animals could therefore become infected and excrete virus over a given period, thus becoming a potential source of infection for humans. This could explain certain as yet un-elucidated human infections. It now appears necessary to assess the role of dogs in Ebola fever outbreaks and take this risk into account in epidemic-control measures. These animals could furthermore be used as indicators of the presence of the virus in the regions where, besides the appearance of cases of both animal and human deaths, there is no external sign as to whether or not Ebola virus is present.
This research work as a whole indicates the progress that has been made over the past years in the understanding the ways in which the virus circulates in its natural environment. Although the reservoir has not yet been identified, investigations are under way to identify the stages which, starting from this reservoir, lead to the emergence of human epidemics. Knowledge of the reservoir animal and of the virus's natural cycle should assist in devising suitable prevention strategies against Ebola epidemics.
(1) This research, conducted since 2001, involves a partnership between the IRD, the CIRMF (Centre International de Recherches Médicales de Franceville, Gabon), the Center for Diseases Control and Prevention of Atlanta (USA) and the Centre Pasteur of Cameroon.
(2) See Scientific news sheet n° 192 - Jabuary 2004, " Virus Ebola : les populations de grands singes menacées ". reference publication: E.M. Leroy, P. Rouquet, P. Formenty, S. Souquie're, A. Kilbourne, J.M. Froment, M. Bermejo, S. Smit, W. Karesh, R. Swanepoel, S. R. Zaki, and P.E. Rollin- Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife, Science, vol. 303 n° 5655, 16 January 2004.
(3) The virus which is rife in Gabon, the Republic of Congo and the Democratic Republic of Congo belongs to the most widespread and most virulent of the four known Ebola sub-groups, the Zaire sub-type, which exists in several strains.
Institut de Recherche pour le Développement, Paris (IRD)
Moreover, during the latest epidemics in Gabon and the Republic of Congo, there were many cases where dogs had eaten remains of dead animals infected with the virus, nonetheless without showing visible clinical signs. In order to confirm that these dogs had indeed come into contact with the virus, the scientists looked for the presence of specific Ebola virus antibodies in their blood (3). The percentage of dogs carrying such antibodies increases linearly and significantly the closer they are found to foci of the outbreaks. From 9 % in the two large cities of Gabon, antibody prevalence goes up to 25 % in the untouched villages of the epidemic area, reaching 32 % in the villages where human cases have been attributed to an infected-animal source. These domestic animals could therefore become infected and excrete virus over a given period, thus becoming a potential source of infection for humans. This could explain certain as yet un-elucidated human infections. It now appears necessary to assess the role of dogs in Ebola fever outbreaks and take this risk into account in epidemic-control measures. These animals could furthermore be used as indicators of the presence of the virus in the regions where, besides the appearance of cases of both animal and human deaths, there is no external sign as to whether or not Ebola virus is present.
This research work as a whole indicates the progress that has been made over the past years in the understanding the ways in which the virus circulates in its natural environment. Although the reservoir has not yet been identified, investigations are under way to identify the stages which, starting from this reservoir, lead to the emergence of human epidemics. Knowledge of the reservoir animal and of the virus's natural cycle should assist in devising suitable prevention strategies against Ebola epidemics.
(1) This research, conducted since 2001, involves a partnership between the IRD, the CIRMF (Centre International de Recherches Médicales de Franceville, Gabon), the Center for Diseases Control and Prevention of Atlanta (USA) and the Centre Pasteur of Cameroon.
(2) See Scientific news sheet n° 192 - Jabuary 2004, " Virus Ebola : les populations de grands singes menacées ". reference publication: E.M. Leroy, P. Rouquet, P. Formenty, S. Souquie're, A. Kilbourne, J.M. Froment, M. Bermejo, S. Smit, W. Karesh, R. Swanepoel, S. R. Zaki, and P.E. Rollin- Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife, Science, vol. 303 n° 5655, 16 January 2004.
(3) The virus which is rife in Gabon, the Republic of Congo and the Democratic Republic of Congo belongs to the most widespread and most virulent of the four known Ebola sub-groups, the Zaire sub-type, which exists in several strains.
Institut de Recherche pour le Développement, Paris (IRD)
Ebola Current Events and Ebola News RSS1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.
Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.
World will miss 2010 target to stem biodiversity loss, experts say
The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science.
Scientists block Ebola infection in cell-culture experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.
OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
Drug blocks 2 of world's deadliest emerging viruses
Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology.
Penn Study Identifies How Ebola Virus Avoids the Immune System
Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus. Using a cell culture model for Ebola virus infection, they have discovered that the virus disables a cellular protein called tetherin that normally can block the spread of virus from cell to cell.
Iowa State University researchers discover structure of key Ebola protein
Research led by Iowa State University scientists has them a step closer to finding a way to counter the Ebola virus.
UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.
More Ebola Current Events and Ebola News Articles
 |
Ebola: Through the Eyes of the People by William T. Close (Author) At a Catholic Mission in Yambuku, an oasis of peace and efficiency in northern Congo's vast jungle forests, Mabalo Lokela, a teacher, receives an anti-malarial shot for a raging fever and headache. Sister Lucie, a Flemish nursing sister, swishes out a syringe with a weak disinfectant. The next patients are injected with the same syringe and the sick man's virus spreads. Lokela was the first Congolese victim of a new African hemorrhagic disease that became known as Ebola fever. When Sister Lucie dies a few days later, panic erupts and hospitalized patients flee into the forest. With the convent connected to the outside world by a single primitive radio, the mission nuns can only pray and wonder if anyone will act on their cries for help. |
 |
NOVA: Ebola - The Plague Fighters Starring: Nova Directed By: Nova Enter the "hot zone" of one of the most frightful diseases on the planet- Ebola. When a dreaded outbreak of the deadly Ebola virus swept through a remote region of Zaire in May 1995, NOVA was the only film crew permitted into the "hot zone." Spending a total of four weeks in the quarantined city of Kikwit, the result is unprecedented journalistic coverage of this grim battle against one of the world's most lethal diseases. The Ebola plague kills a very high percentage of its victims (77% in Kikwit), often by dissolving their internal organs and connective tissue. Learn how disease specialists traced the origins of the outbreak by compiling a complete "chain of death" of the epidemic, and why they fear a mutation of Ebola will emerge that is even more difficult to contain. |
 |
EBOLA GIANT MICROBE PLUSH by Giant Microbes Since its discovery in 1976, Ebola has become the T. Rex of microbes. Share the love! |
 |
Ebola by Dr. William Close (Author) IT STRIKES WITHOUT WARNING--A HORRIFYING, LETHAL DISEASE WITH NO NAME. AND NO CURE. . . . Now, from the molten center of the "hot zone," comes a terrifying, completely authentic novel of medical suspense by William T. Close, M.D., the American physician who lived in Zaire for sixteen years, and who worked desperately to contain the first outbreak of the virus in 1976. Haunted by the images from this wrenching time, and unable to forget the people he knew and lost, Dr. Close was compelled to tell their story. EBOLA, inspired by his personal experience and based upon extensive research, is an unforgettable portrait of this devastating drama, which all began with an invisible, unknown killer . . . . EBOLA At a Catholic mission in Yambuku, a remote area of Zaire, Mabalo Lokela, a local... |
 |
The Hot Zone: A Terrifying True Story by Richard Preston (Author) A highly infectious, deadly virus from the central African rain forest suddenly appears in the suburbs of Washington, D.C. There is no cure. In a few days 90 percent of its victims are dead. A secret military SWAT team of soldiers and scientists is mobilized to stop the outbreak of this exotic "hot" virus. The Hot Zone tells this dramatic story, giving a hair-raising account of the appearance of rare and lethal viruses and their "crashes" into the human race. Shocking, frightening, and impossible to ignore, The Hot Zone proves that truth really is scarier than fiction. From the Paperback edition. |
 |
Ebola Syndrome Starring: Anthony Wong Chau-Sang, Yeung Ming Wan, Fui-On Shing, Wong Tsui-ling, Miu-Ying Chan Directed By: Herman Yau Also With: Jing Wong (Producer), Ting Chau (Writer)
Kai San is a sleazy and despicable bastard of the most epic proportions! After being caught screwing the wife of his boss, he goes on a killing spree and flees Hong Kong. 10 years later, Kai finds himself working as a restaurant chef in South Africa. Overworked, underpaid, berated, and extorted by the restaurant owners who know of his fugitive status, Kai is a ticking timebomb... While visiting an ebola infected... |
 |
Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional? by Leonard G. Horowitz (Author) |
![Ebola Mini Plush in Petri Dish by Giant Microbes [Toy] [Toy]](http://ecx.images-amazon.com/images/I/31nFEWDHwzL._SL160_.jpg) |
Ebola Mini Plush in Petri Dish by Giant Microbes [Toy] [Toy] by Giant Microbes set of 3 MiniPlush Ebola viruses in therir very own petri dish by Giant Microbes |
 |
NOVA: Epidemic - Ebola, AIDS, Bird Flu and Typhoid Starring: Nova Directed By: Nova Includes four programs: NOVA-Ebola The Plague Fighters; NOVA-Surviving AIDS, NOVA-Typhoid Mary: The Most Dangerous Woman in America; and Rx for Survival-Bird Flu. |
 |
Ebola (Deadly Diseases and Epidemics) by Tara C. Smith (Author) |
| © 2009 BrightSurf.com |